Protection against Doxorubicin-Induced Cardiac Dysfunction Is Not Maintained Following Prolonged Autophagy Inhibition

Doxorubicin (DOX) is a highly effective chemotherapeutic agent used in the treatment of various cancer types. Nevertheless, it is well known that DOX promotes the development of severe cardiovascular complications. Therefore, investigation into the underlying mechanisms that drive DOX-induced cardio...

Descripción completa

Detalles Bibliográficos
Autores principales: Montalvo, Ryan N., Doerr, Vivian, Kwon, Oh Sung, Talbert, Erin E., Yoo, Jeung-Ki, Hwang, Moon-Hyon, Nguyen, Branden L., Christou, Demetra D., Kavazis, Andreas N., Smuder, Ashley J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662380/
https://www.ncbi.nlm.nih.gov/pubmed/33143122
http://dx.doi.org/10.3390/ijms21218105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662380/
https://www.ncbi.nlm.nih.gov/pubmed/33143122
http://dx.doi.org/10.3390/ijms21218105

Ejemplares similares